ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Physician Assistant, Medical

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,894Medicare Part D Prescriptions Filled, Including Refills

Rank: 2 out of 141

$581K Total Retail Price of All Prescriptions

Rank: 5 out of 141

742 Patients Receiving at Least One Drug in Part D
47%Patients 65 Years and Older
84% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Tennessee
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 742 patients filled at least one prescription for a schedule two drug, compared to an average of 13%.

Schedule Three
Controlled Substances

34% of this provider’s 742 patients filled at least one prescription for a schedule three drug, compared to an average of 21%.

Risky Drugs to Seniors

3% of this provider’s 5,028 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 18%.

Prescription Price

$49 was the average price of a prescription from this provider, compared to $59 among peers.

Prescriptions per Patient

16 is the average number of prescriptions (including refills) per patient, compared to an average of 9.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Tennessee
HYDROCODONE-ACETAMINOPHEN 1,281 458 S3 1 1
LISINOPRIL 494 171 2 2
TRAMADOL HCL 476 143 3 20
OMEPRAZOLE 369 147 4 6
METFORMIN HCL 359 181 5 7
SIMVASTATIN 278 147 6 3
LISINOPRIL-HYDROCHLOROTHIAZIDE 250 151 7 28
AMLODIPINE BESYLATE 245 125 8 11
ZOLPIDEM TARTRATE 238 69 9 17
LEVOTHYROXINE SODIUM 212 75 10 4
FUROSEMIDE 194 117 11 10
LOVASTATIN 184 104 12 26
NEXIUM 180 45 13 21
RANITIDINE HCL 179 74 14 22
METOPROLOL TARTRATE 174 118 15 12
SERTRALINE HCL 173 55 16 42
MELOXICAM 167 77 17 16
ATENOLOL 167 70 17 19
AZITHROMYCIN 155 71 19 25
SPIRIVA 153 54 20 50
WARFARIN SODIUM 147 40 21 30
HYDROCHLOROTHIAZIDE 147 69 21 13
PROAIR HFA 136 48 23 32
GLYBURIDE 121 58 R 24 52
CARVEDILOL 121 71 24 36
GABAPENTIN 119 19 26 5
CRESTOR 116 59 27 35
ATORVASTATIN CALCIUM 111 46 28 41
NAPROXEN SODIUM 91 24 29 141
CELEBREX 91 73 29 110
IBUPROFEN 89 38 31 66
AMLODIPINE BESYLATE-BENAZEPRIL 88 53 32 107
CITALOPRAM HBR 81 35 33 23
TRAZODONE HCL 78 27 34 49
TIZANIDINE HCL 77 40 35 24
CLOPIDOGREL 77 46 35 39
POTASSIUM CHLORIDE 75 54 37 29
ALENDRONATE SODIUM 73 27 38 67
PREDNISONE 73 30 38 31
ACETAMINOPHEN-CODEINE 72 41 S3 40 100
SINGULAIR 63 20 41 94
PROMETHAZINE HCL 60 24 R 42 34
METHOCARBAMOL 59 19 R 43 63
ACTOPLUS MET 58 30 44 164
PRAVASTATIN SODIUM 57 14 45 27
FLUTICASONE PROPIONATE 53 20 46 44
TRIAMTERENE-HCTZ 52 26 47 79
TRILIPIX 52 11 47 177
CYCLOBENZAPRINE HCL 51 12 R 49 40
VENLAFAXINE HCL ER 51 17 49 125
SPIRONOLACTONE 50 0 51 92
CIPROFLOXACIN HCL 50 27 51 43
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on June 17, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.